Page last updated: 2024-08-16

salmeterol xinafoate and Eosinophilic Esophagitis

salmeterol xinafoate has been researched along with Eosinophilic Esophagitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collison, AM; Fevre, AL; Foster, PS; Hansbro, PM; Mattes, J; Nightingale, S; Percival, E; Sokulsky, LA; Starkey, MR1

Other Studies

1 other study(ies) available for salmeterol xinafoate and Eosinophilic Esophagitis

ArticleYear
TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis.
    American journal of physiology. Gastrointestinal and liver physiology, 2016, 12-01, Volume: 311, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Bronchodilator Agents; Case-Control Studies; Chemokine CCL11; Child; Cytokines; Dexamethasone; Egg Hypersensitivity; Eosinophilic Esophagitis; Female; Fibrosis; Humans; Interleukin-3; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Microtubule Proteins; Nuclear Proteins; Ovalbumin; Protein Phosphatase 2; Salmeterol Xinafoate; Thymic Stromal Lymphopoietin; TNF-Related Apoptosis-Inducing Ligand; Transcription Factors; Ubiquitin-Protein Ligases

2016